Curium to market xenon-133 gas in the U.S.

Global nuclear medicine firm Curium has expanded its U.S. offerings to include...Read more on AuntMinnie.comRelated Reading:
Can nuclear medicine avoid another Mo-99 shortage?
NorthStar's novel generator could relieve U.S. isotope shortages
SNMMI urges CMS to classify radiotracers as drugs
Curium switches Mo-99 production process to LEU
IBA Molecular forms Curium as new radiopharmacy player

Source: AuntMinnie.com Headlines - May 10, 2018 Category: Radiology Source Type: news